Abstract
Among concepts proposed to elucidate atherosclerosis process, the oxidative modification hypothesis is more considered to be investigated in studies. Based on the hypothesis, the LDL components are chemically modified due to oxidative stress within subendothelial space of vessels. The cells are able to recognize the oxidized LDL (ox-LDL) preparations so that inflammatory events spread through intracellular pathways and lead to the cellular dysfunction and the production of atherosclerotic plaques. The circulating ox-LDL level is suggested as biomarker of atherogenic lesions. However, it is not confirmed in some studies since the circulating ox-LDL clearance during the extent of atherosclerosis process is related to function of scavenger receptors and the serum anti LDL levels. The report is focused on the biochemical characteristics of modified LDL components, the cellular internalization of ox-LDL particles through the scavenger receptors, prediction of consensus blocks in the receptor sequences and the circulating ox-LDL assessments in cardiovascular complications.
Keywords: Ox-LDL, Components, Scavenger receptors, Blocks, Cardiovascular disease, Lysophosphatidylcholine, sn-2 acyl group, PAF-AH enzymes, chain-oxidized oxysterols, malondialdehyde
Cardiovascular & Hematological Disorders-Drug Targets
Title: Ox-LDL Particles: Modified Components, Cellular Uptake, Biological Roles and Clinical Assessments
Volume: 11 Issue: 2
Author(s): Mohammad Najafi, Abazar Roustazadeh and Behnam Alipoor
Affiliation:
Keywords: Ox-LDL, Components, Scavenger receptors, Blocks, Cardiovascular disease, Lysophosphatidylcholine, sn-2 acyl group, PAF-AH enzymes, chain-oxidized oxysterols, malondialdehyde
Abstract: Among concepts proposed to elucidate atherosclerosis process, the oxidative modification hypothesis is more considered to be investigated in studies. Based on the hypothesis, the LDL components are chemically modified due to oxidative stress within subendothelial space of vessels. The cells are able to recognize the oxidized LDL (ox-LDL) preparations so that inflammatory events spread through intracellular pathways and lead to the cellular dysfunction and the production of atherosclerotic plaques. The circulating ox-LDL level is suggested as biomarker of atherogenic lesions. However, it is not confirmed in some studies since the circulating ox-LDL clearance during the extent of atherosclerosis process is related to function of scavenger receptors and the serum anti LDL levels. The report is focused on the biochemical characteristics of modified LDL components, the cellular internalization of ox-LDL particles through the scavenger receptors, prediction of consensus blocks in the receptor sequences and the circulating ox-LDL assessments in cardiovascular complications.
Export Options
About this article
Cite this article as:
Najafi Mohammad, Roustazadeh Abazar and Alipoor Behnam, Ox-LDL Particles: Modified Components, Cellular Uptake, Biological Roles and Clinical Assessments, Cardiovascular & Hematological Disorders-Drug Targets 2011; 11 (2) . https://dx.doi.org/10.2174/187152911798346990
DOI https://dx.doi.org/10.2174/187152911798346990 |
Print ISSN 1871-529X |
Publisher Name Bentham Science Publisher |
Online ISSN 2212-4063 |
- Author Guidelines
- Graphical Abstracts
- Fabricating and Stating False Information
- Research Misconduct
- Post Publication Discussions and Corrections
- Publishing Ethics and Rectitude
- Increase Visibility of Your Article
- Archiving Policies
- Peer Review Workflow
- Order Your Article Before Print
- Promote Your Article
- Manuscript Transfer Facility
- Editorial Policies
- Allegations from Whistleblowers
- Announcements
Related Articles
-
Effects of High Altitude Exposure on Physiology and Pharmacokinetics
Current Drug Metabolism Cytokine-Directed Therapy in Asthma
Current Drug Targets - Inflammation & Allergy Repurposing of the PDE5 Inhibitor Sildenafil for the Treatment of Persistent Pulmonary Hypertension in Neonates
Current Medicinal Chemistry Nucleotide-Derived Thrombin Inhibitors: A New Tool for an Old Issue
Cardiovascular & Hematological Agents in Medicinal Chemistry The Spectrum of Nimesulide-Induced-Hepatotoxicity. An Overview
Anti-Inflammatory & Anti-Allergy Agents in Medicinal Chemistry Nanotechnology Advances in Brain Tumors: The State of the Art
Recent Patents on Anti-Cancer Drug Discovery Dietary Melatonin Protects Against Behavioural, Metabolic, Oxidative, and Organ Morphological Changes in Mice that are Fed High-Fat, High- Sugar Diet
Endocrine, Metabolic & Immune Disorders - Drug Targets Ischemic and Oxidative Damage to the Hypothalamus May Be Responsible for Heat Stroke
Current Neuropharmacology Thymosin β4: A Multi-Faceted Tissue Repair Stimulating Protein in Heart Injury
Current Medicinal Chemistry Device-based Therapies for Resistant Hypertension
Current Pharmaceutical Design Novel Therapeutic Agents in the Management of Hemorrhage and Thrombosis
Cardiovascular & Hematological Agents in Medicinal Chemistry Fasting-Evoked En Route Hypoglycemia in Diabetes (FEEHD): From Guidelines to Clinical Practice
Current Diabetes Reviews Influence of Lithium Treatment on GDNF Serum and CSF Concentrations in Patients with Early Alzheimers Disease
Current Alzheimer Research Nitrogen Biobank for Cardiovascular Research
Current Cardiology Reviews Extra-Hematopoietic Effects of Erythropoietin
Cardiovascular & Hematological Disorders-Drug Targets Editorial [Hot Topic: Architecture and Design of Non-Drug Therapy for Reactive Oxygen Spcecies (ROS)-Induced Diseases (Executive Guest Editors: Tohru Yoshioka and Mami Noda)]
Current Pharmaceutical Design Globalization of Clinical Trials – Where are We Heading?
Current Clinical Pharmacology Neurodegeneration and Neurogenesis: Focus on Alzheimers Disease
Current Alzheimer Research HspB5/αB-Crystallin: Properties and Current Progress in Neuropathy
Current Neurovascular Research Early Cerebral Infarction Following Aneurysmal Subarachnoid Hemorrhage: Frequency, Risk Factors, Patterns, and Prognosis
Current Neurovascular Research